A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

221

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

Paclitaxel & Cisplatin

Chemotherapeutic agent

BIOLOGICAL

Mycobacterium w.

Immunomodulator

Trial Locations (14)

144001

Patel Hospital Pvt. Ltd, Jalandhar

171001

Regional Cancer Center, Indira Gandhi Medical College, Shimla

334003

Acharya Tulsi Regional Cancer Treatment & Research Institute, Bikaner

380013

Gujarat Cancer & Research Institute, New Civil Hospital Campus, Asarwa

452014

Choithram Hospital and Research Centre, Indore

500004

MNJ Institute of Oncology, Regional Cancer Centre, Red Hills

641037

V.N. Cancer Center, GKNM Hospital, Coimbatore

673016

Malabar Institute of Medical Science (MIMS), Calicut

700016

Netaji Subash Chandra Bose Cancer Research Institute, Kolkata

700020

Institute of Post Graduate Medical education & Research, Kolkata

700026

Chittaranjan National Cancer Institute, Kolkata

700053

B.P. Poddar Hospital and Medical Research Ltd., New Alipore

722101

Bankura Sammilani Medical College, Gobindnagar

800014

Regional Cancer Centre, Indira Gandhi Institute of Medical Science, Sheikhpura

Sponsors
All Listed Sponsors
lead

Cadila Pharnmaceuticals

INDUSTRY

NCT00680940 - A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter